Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment.
Carpio, D
Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment. [electronic resource] - Journal of Crohn's & colitis Oct 2016 - 1186-93 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study
1876-4479
10.1093/ecco-jcc/jjw022 doi
Adalimumab--therapeutic use
Adult
Female
Follow-Up Studies
Guideline Adherence--statistics & numerical data
Humans
Immunosuppressive Agents--therapeutic use
Inflammatory Bowel Diseases--complications
Infliximab--therapeutic use
Male
Middle Aged
Opportunistic Infections--complications
Practice Guidelines as Topic
Retreatment
Retrospective Studies
Spain
Treatment Outcome
Tuberculin Test--statistics & numerical data
Tuberculosis--complications
Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment. [electronic resource] - Journal of Crohn's & colitis Oct 2016 - 1186-93 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study
1876-4479
10.1093/ecco-jcc/jjw022 doi
Adalimumab--therapeutic use
Adult
Female
Follow-Up Studies
Guideline Adherence--statistics & numerical data
Humans
Immunosuppressive Agents--therapeutic use
Inflammatory Bowel Diseases--complications
Infliximab--therapeutic use
Male
Middle Aged
Opportunistic Infections--complications
Practice Guidelines as Topic
Retreatment
Retrospective Studies
Spain
Treatment Outcome
Tuberculin Test--statistics & numerical data
Tuberculosis--complications